Generalized Anxiety Disorder (GAD), which neurotransmitter abnormality is most commonly associated?

AIIMS M.Sc. Nsg Entrance exam-2026

Mental Health Nursing

Easy

Appeared in: AIIMS M.Sc. Nsg Entrance exam-2026

Explanation

GABA (Gamma-Aminobutyric Acid) is the principal inhibitory neurotransmitter in the central nervous system, acting as the brain's 'calming' agent or 'brake pedal'.
In GAD, a reduction in GABA levels or impaired function of its receptors leads to a state of neuronal hyperexcitability.
This hyperexcitability manifests clinically as the persistent worry, restlessness, and tension characteristic of GAD.
The effectiveness of anxiolytic medications like benzodiazepines, which enhance the effect of GABA, provides strong evidence for this association.

Option A: Dopamine is primarily linked to the brain's reward, pleasure, and motor control systems. An excess of dopamine is more commonly associated with psychosis and schizophrenia, not the core pathology of GAD.
Option B: Acetylcholine is mainly involved in muscle function, learning, and memory. It is not the primary neurotransmitter implicated in anxiety disorders.
Option C: The serotonin system is dysregulated in anxiety, but the underlying problem is not a simple excess. In fact, first-line treatments like SSRIs work by increasing the availability of serotonin to alleviate symptoms, suggesting a deficit or dysregulation rather than an excess.

Visual 1: Diagram - A diagram of a GABAergic synapse, showing GABA release from the presynaptic terminal and binding to GABA-A receptors on the postsynaptic membrane. This illustrates the resulting influx of chloride ions that leads to hyperpolarization (inhibition) of the neuron.
Visual 2: Infographic - A simple infographic comparing a 'balanced brain' with adequate GABA function (calm, regulated) versus a 'GAD brain' with low GABA function (anxious, over-stimulated, racing thoughts).

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Neurotransmitter pathophysiology of Generalized Anxiety Disorder (GAD) as background academic context rather than a clinical decision trigger.
Understanding the role of GABA helps nurses educate patients about how anxiolytic medications like benzodiazepines work to reduce their symptoms of anxiety.
Nurses must be vigilant in assessing for and educating about the risks of tolerance, dependence, and withdrawal associated with long-term benzodiazepine use, as these drugs act directly on the GABA system.
Patient education should also include non-pharmacological methods to boost GABA naturally, such as yoga, meditation, and exercise.

How to Approach the Question

First, identify the key concepts in the question: 'Generalized Anxiety Disorder (GAD)' and 'neurotransmitter abnormality'.
This is a factual recall question that tests your knowledge of basic neurobiology in common psychiatric conditions.
Think of the core experience of anxiety: a state of mental and physical 'over-activity,' 'hyperexcitability,' or being 'on edge.'
Recall the primary functions of the major neurotransmitters. GABA is the main 'inhibitory' or 'braking' neurotransmitter in the brain.
Logically connect the state of over-activity (anxiety) with a failure of the brain's braking system. A decrease in the primary inhibitory neurotransmitter (GABA) is the most direct cause of this hyperexcitability.
Eliminate the other options by recalling their primary roles: Dopamine (reward/psychosis), Acetylcholine (memory/muscles), and Serotonin (complex mood regulation, where treatment involves increasing it).

Concept Tested & Keywords

Concept Tested: Neurotransmitter pathophysiology of Generalized Anxiety Disorder (GAD)
Stem keywords: Generalized Anxiety Disorder, GAD, neurotransmitter abnormality
Lead-in keywords: most commonly associated
Negative lead-in flag: false

QZrfqefkMFGWLaGgfzOp28